The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
Rightly or wrongly, Americans perceive people with straight teeth as more attractive, successful, and employable than those without, according to studies. Hence, an investment into treatments for teeth straightening has the potential to really pay off in the long run. One such t
Amazon (NASDAQ: AMZN) just revealed its latest step into the healthcare industry , a multi-trillion-dollar opportunity that the tech giant has been increasingly eyeing in recent years. Amazon has acquired an online pharmacy, PillPack, partnered with JPMorgan Chase (NYSE: JPM)
The prevailing wisdom in investing seems to be "buy low, sell high." This is easy to say but very tough to do. The problem is that investors tend to gravitate toward cheap stocks to "buy low," not realizing that buying cheap stocks is not the solution for their investment portfo
Whatever one's particular stance on the economic response to COVID-19, one thing is now becoming undeniable: Many businesses are being rendered redundant, and it's unclear how relevant many of them will be once the lockdown ends. Restaurants have been hit hard, and switching to
Beyond Meat (NASDAQ: BYND) is an up-and-coming industry disrupter with an uncertain -- but promising -- future. Its business has flourished despite the pandemic, which shows just how competitive it is. Nike (NYSE: NKE) is a leading athletic wear company. It's seen a dip in sales
After the March market crash, some investors scooped up the usually strong stocks that had a difficult spell. They may take a while to rebound, but long-term investors know that's OK, and the purchases will bear fruit in the coming months or years. Others opted for shares that s
Traders who use the investing app and website for the financial services company Robinhood seem to have a propensity for liking volatile stocks that can create opportunities to trade the technicals (i.e., trading on whatever is trending) and benefit from short-term gains. As a g
Investors have always loved dividend stocks for their combination of growth potential and current income. With interest rates at rock-bottom levels, it's hard to find good income-producing alternatives to dividend stocks right now. Yet with the coronavirus pandemic raging on, ma
Since March 15, 2020, as investors began to understand the effects of the COVID-19 pandemic on consumer behavior, Carvana (NYSE: CVNA) shares have increased roughly 167% compared to the S&P 500's 19% gain. Carvana outshined a vast majority of auto stocks, simply because its
We're only halfway through the year, and 2020 has already been an intense rollercoaster ride. The U.S. officially entered a recession back in February, according to the National Bureau of Economic Research, but the stock market has been surging in recent weeks.
Netflix (NASDAQ: NFLX) reported second-quarter earnings this Thursday evening. The video-streaming veteran crushed subscriber-addition forecasts with the caveat that the next couple of quarters will be slower. Revenues rose 25% year over year to $6.15 billion, and earnings fell
Amazon (NASDAQ: AMZN) is experiencing a surge in sales as a result of the COVID-19 pandemic. Customers avoiding making extra trips to the store are turning to the e-commerce giant for deliveries of essentials and other products. Given the recent resurgence of coronavirus cases i
A few major healthcare businesses have seen their share prices fall significantly over the past several months. Elanco Animal Health (NYSE: ELAN), a $9.6 billion company that (unsurprisingly) takes care of animals' health, has seen its stock price tumble by about 20% since the b
With more than 13 million cases of COVID-19 around the globe and the number continuing to climb, there's plenty of incentive for healthcare companies to try to develop a treatment or a vaccine to stop the spread of the disease. But developing a vaccine takes time, and investors
Checked
30 minutes 48 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article